Characterization of tumor and immune tumor microenvironment of primary tumors and metastatic sites in advanced renal cell carcinoma patients based on response to nivolumab immunotherapy: preliminary results from the meet-uro 18 study

HIGHLIGHTS

  • who: Sara Elena Rebuzzi and colleagues from the Medical Oncology Unit, Ospedale San, Savona, Italy Department of Internal Medicine and Medical Specialties (DiMI.), University of Genoa, Genoa, Italy have published the article: Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study, in the Journal: (JOURNAL)
  • what: The aim was to identify differential immunohistochemical (IHC) patterns between the two groups. The authors report the IHC analyses of this study, while the molecular . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?